Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?

NCT02286843 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Metastases
HER2 Positive Breast

Interventions

RADIATION: 89Zr-trastuzumab
DEVICE: PET/CT scan
RADIATION: 89Zr-pertuzumab

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]